SMTL ID : 6l9l.2 (1 other biounit)

1D4 TCR recognition of H2-Ld a1a2 A5 Peptide Complexes

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x SER- PRO- SER- TYR- ALA- TYR- HIS- GLN- PHE: SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE(Non-covalent)

SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE.1: 40 residues within 4Å: Chain A: M.5, Y.7, Y.45, R.62, I.63, I.66, G.69, Q.70, W.73, V.76, N.77, T.80, L.81, Y.84, L.95, R.97, Y.99, F.116, T.143, K.146, W.147, A.150, A.152, Y.155, Y.156, Y.159, W.167, Y.171 Chain B: N.29, Y.31, Y.33, Q.90, G.91, T.92, G.93 Chain C: N.28, D.93, G.94, D.95, Y.96 40 PLIP interactions: 6 interactions with chain C, 29 interactions with chain A, 5 interactions with chain B Hydrophobic interactions: C:D.95, C:Y.96, A:Y.45, A:W.73, A:W.73, A:N.77, A:L.81, A:L.81, A:L.95, A:F.116, A:T.143, A:W.147, A:Y.155, B:N.29, B:Y.31, B:Y.31 Hydrogen bonds: C:N.28, C:D.95, C:Y.96, C:Y.96, A:Y.7, A:R.62, A:R.62, A:Q.70, A:W.73, A:N.77, A:R.97, A:R.97, A:Y.99, A:T.143, A:K.146, A:Y.159, A:W.167, A:Y.171, A:Y.171, B:N.29, B:Y.33 Water bridges: A:Y.99 Salt bridges: A:K.146 pi-Stacking: A:W.73

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wei, P. et al., Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Proc.Natl.Acad.Sci.USA (2021)

Release Date

2020-11-18

Peptides

H2-Ld a1a2: A
T Cell Receptor: B
T Cell Receptor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
G

C
H

H2-Ld a1a2

T Cell Receptor

T Cell Receptor

Related Entries With Identical Sequence